Advances in endoscopic balloon therapy for weight loss and its limitations

doi:10.3748/wjg.v23.i44.7813

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 44

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11571)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

641

WORD

221

HTML

4515

Figures (1-1)

535

Tables (1-1)

591

Sum=6503

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

755

Download

1195

Sum=1950

Publishing Process of This Article

Item

Count

Browse

1376

Download

1741

Sum=3117

Nov 28, 2017 (publication date) through Mar 9, 2026

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Editorial

World J Gastroenterol. Nov 28, 2017; 23(44): 7813-7817
Published online Nov 28, 2017. doi: 10.3748/wjg.v23.i44.7813

Advances in endoscopic balloon therapy for weight loss and its limitations

Dinesh Vyas, Kaivalya Deshpande, Yagnik Pandya

Dinesh Vyas, Department of Surgery, Texas Tech University, Odessa, TX 79763, United States

Kaivalya Deshpande, Department Of Surgery, Michigan State University, Lansing, MI 48912, United States

Yagnik Pandya, Department of Surgery, MetroWest Medical Center, Natick, MA 01760, United States

Author contributions: Vyas D contributed with concept design; Vyas D, Deshpande K and Pandya Y contributed with research, writing and final approval.

Conflict-of-interest statement: All authors have no stated conflicts of interest related to this publication.

Correspondence to: Dinesh Vyas, MD, FACS, Associate Dean of Surgery Research, Department of Surgery, Texas Tech University, 701 West 5th Street, Suite 2263, Odessa, TX 79763, United States. dvyas@sjgh.org

Telephone: +1-314-680134 Fax: +1-314-2607609

Received: October 5, 2017
Peer-review started: October 7, 2017
First decision: October 25, 2017
Revised: November 4, 2017
Accepted: November 15, 2017
Article in press: November 15, 2017
Published online: November 28, 2017
Processing time: 53 Days and 0.9 Hours

Abstract

The field of medical and surgical weight loss is undergoing an explosion of new techniques and devices. A lot of these are geared towards endoscopic approaches rather than the conventional and more invasive laparoscopic or open approach. One such recent advance is the introduction of intrgastric balloons. In this article, we discuss the recently Food and Drug Administration approved following balloons for weight loss: the Orbera™ Intragastric Balloon System (Apollo Endosurgery Inc, Austin, TX, United States), the ReShape^® Integrated Dual Balloon System (ReShape Medical, Inc., San Clemente, CA, United States), and the Obalon (Obalon^® Therapeutics, Inc.). The individual features of each of these balloons, the method of introduction and removal, and the expected weight loss and possible complications are discussed. This review of the various balloons highlights the innovation in the field of weight loss.

Keywords: Weight loss; Gastric balloons; Endoscopic balloons; Orbera; Obalon; Reshape

Core tip: This review has been elucidated through a comparison of the strengths and weaknesses of recent balloon approaches, highlighting the indications and possible complications.